Participants
myocardial/pericardial disease, valvular disease, myocardial infarction/ischemia, diabetes
THYROID DISORDERS, HEART FAILURE, HYPERTENSION, DIABETES
A total of 18 community‐dwelling women with a mean age, height, weight, and body mass index of 70 ± 4 years, 1.65 ± 0.06 m, 67.1 ± 9.5 kg, and 24.6 ± 3.2 kg/mCONSORT diagram illustrating flow of subjects through the study.Individuals were excluded if they were not between the ages of 65 and 79 years, were unable to provide informed consent, were currently smokers, pregnant, or lactating, were taking proton pump inhibitors, antacids, or xanthine oxidoreductase inhibitors, or had a history of major metabolic (thyroid disorders, type I or II diabetes), cardiovascular (e.g., moderate or severe valvular disease, myocardial/pericardial disease, stage II or greater hypertension, heart failure, myocardial infarction/ischemia), renal (eGFR <60 mL/min/1.73 m